Too Good to Be True? The Promises and Risks of Compounded Peptides - Frankly Speaking Ep 484
Frankly Speaking About Family MedicineShow Notes
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484 Overview: Muscle growth, tissue repair, sexual function—compounded injectable peptides are marketed online for an expanding list of uses, and they’re showing up in your patients’ medicine cabinets. Join us as we explore this growing trend, evaluate the evidence behind the claims, and discuss how to counsel patients on potential safety risks. Episode resource links:
Expert Opin Drug Saf. 2026 Mar;25(3):581-588. doi: 10.1080/14740338.2025.2499670HSS J. 2025 Jul 31;21(4):15563316251355551. doi: 10.1177/15563316251355551JAMA 2017;318;(20):2004-2010. doi:10.1001/jama.2017.17069
Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
More from Frankly Speaking About Family Medicine
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-507 Overview: Falls in older adults can have devastating consequences; substance use and prescription medications are often-overlooked risk factors. Tune in to explore how screening for substance use in a primary care environment may decrease fall and related injury risk in adults over 55. Come away with stronger identification and prevention practices. Episode resource links:
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-506 Overview: Overview copy Episode resource links:
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-505 Overview: The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) reflects the true complexity of this diagnosis—a condition that extends beyond ovarian cysts and reproductive health. Listen in as we explore what drove the name change, how it better reflects the condition’s complexity, and what current evidence says about prevalence, risk, and whole-body management strategies for your patients. Episode resource links:
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-504 Overview: In this episode, we discuss the American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines, explore where the evidence may support or challenge recommendations, and provide practical frameworks for implementing lifestyle interventions to improve the outcomes of hypertension care. Episode resource links: Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-503 Overview: In this episode, we discuss how prescribing “food as medicine” can complement hypertension management in primary care. We review the evidence supporting legumes, soy, and DASH-based nutrition for lowering blood pressure, while providing practical counseling strategies to help patients adopt dietary patterns that enhance cardiovascular health alongside standard medical therapy. Episode resource links: